Veeva to Present at the J.P. Morgan 2026 Healthcare Conference
Rhea-AI Summary
Veeva Systems (NYSE: VEEV) will present at the J.P. Morgan 2026 Healthcare Conference in San Francisco. Brian Van Wagener, CFO, will present on Tuesday, January 13, 2026 at 1:30 p.m. PT. The presentation will be webcast live and an archived webcast will be available on Veeva's investor relations website.
Positive
- None.
Negative
- None.
News Market Reaction – VEEV
In the Jan 9 session, VEEV declined 0.43%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jan 05 | Share repurchase plan | Positive | +0.8% | Board authorized up to $2.0B Class A share repurchases over two years. |
| Dec 04 | Investor conference | Neutral | -0.1% | Announcement of Raymond James 2025 TMT and Consumer Conference presentation. |
| Dec 03 | AI product launch | Positive | +0.5% | Launch of Veeva AI Agents for Vault CRM and PromoMats to enhance productivity. |
| Nov 24 | Partnership expansion | Positive | -3.4% | Roche expanded adoption of Veeva Vault CRM and Veeva AI across pharma unit. |
| Nov 20 | Earnings results | Positive | -0.9% | Fiscal 2026 Q3 results with revenue and income growth plus forward guidance. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Positive strategic and product news often saw modest or mixed price reactions, with some notable divergences on strong fundamental updates and partnerships.
Over recent months, Veeva announced a $2.0 billion share repurchase program, launched Veeva AI Agents, and expanded its partnership with Roche Pharmaceuticals around Veeva Vault CRM and Veeva AI. Fiscal 2026 Q3 results showed total revenues of $811.2M, up 16% year over year, with guidance for Q4 and full-year revenues. Conference participation, like the Raymond James 2025 event, and today’s J.P. Morgan appearance reflect ongoing investor outreach alongside these operational milestones.
AI-generated analysis. How Rhea-AI works. Not financial advice.
- J.P. Morgan 2026 Healthcare Conference,
San Francisco, CA . Brian Van Wagener, CFO, will present on Tuesday, January 13, 2026, at 1:30 p.m. Pacific Time.
The above presentation will be webcast. Links to the live and archived webcast will be available on Veeva's investor relations website at https://ir.veeva.com.
About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,500 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
Veeva uses its ir.veeva.com website as a means of disclosing material non-public information, announcing upcoming investor conferences, and for complying with its disclosure obligations under Regulation FD. Accordingly, you should monitor Veeva's investor relations website in addition to following its press releases, SEC filings, and public conference calls and webcasts.
Investor Relations Contact:
Gunnar Hansen
Veeva Systems Inc.
267-460-5839
ir@veeva.com
Media Contact:
Maria Scurry
Veeva Systems Inc.
781-366-7617
pr@veeva.com
View original content:https://www.prnewswire.com/news-releases/veeva-to-present-at-the-jp-morgan-2026-healthcare-conference-302656697.html
SOURCE Veeva Systems